245 related articles for article (PubMed ID: 12803789)
1. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
Bilgen C; Ogüt F; Kesimli-Dinç H; Kirazli T; Bor S
J Laryngol Otol; 2003 May; 117(5):386-90. PubMed ID: 12803789
[TBL] [Abstract][Full Text] [Related]
2. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
[TBL] [Abstract][Full Text] [Related]
3. Laryngopharyngeal reflux symptoms improve before changes in physical findings.
Belafsky PC; Postma GN; Koufman JA
Laryngoscope; 2001 Jun; 111(6):979-81. PubMed ID: 11404607
[TBL] [Abstract][Full Text] [Related]
4. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
Katzka DA; Paoletti V; Leite L; Castell DO
Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
[TBL] [Abstract][Full Text] [Related]
5. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
[TBL] [Abstract][Full Text] [Related]
6. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
7. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
[TBL] [Abstract][Full Text] [Related]
8. [Laryngopharyngeal reflux].
Takeda H; Oridate N; Shimizu Y; Kato M; Asaka M; Fukuda S; Yamamoto J
Nihon Rinsho; 2007 May; 65(5):921-5. PubMed ID: 17511234
[TBL] [Abstract][Full Text] [Related]
9. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebo-controlled study.
Pawar S; Lim HJ; Gill M; Smith TL; Merati A; Toohill RJ; Loehrl TA
Am J Rhinol; 2007; 21(6):695-701. PubMed ID: 18201449
[TBL] [Abstract][Full Text] [Related]
10. Voice disorders and gastroesophageal reflux.
Sereg-Bahar M; Jansa R; Hocevar-Boltezar I
Logoped Phoniatr Vocol; 2005; 30(3-4):120-4. PubMed ID: 16287651
[TBL] [Abstract][Full Text] [Related]
11. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
Omari TI; Haslam RR; Lundborg P; Davidson GP
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
[TBL] [Abstract][Full Text] [Related]
12. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
Issing WJ; Tauber S; Folwaczny C; Reichel O
Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
[TBL] [Abstract][Full Text] [Related]
13. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
[TBL] [Abstract][Full Text] [Related]
14. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
Zerbib F; Roman S; Ropert A; des Varannes SB; Pouderoux P; Chaput U; Mion F; Vérin E; Galmiche JP; Sifrim D
Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
[TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
Ours TM; Kavuru MS; Schilz RJ; Richter JE
Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
[TBL] [Abstract][Full Text] [Related]
16. Do the laryngopharyngeal symptoms and signs ameliorate by empiric treatment in patients with suspected laryngopharyngeal reflux?
Naiboglu B; Durmus R; Tek A; Toros SZ; Egeli E
Auris Nasus Larynx; 2011 Oct; 38(5):622-7. PubMed ID: 21320761
[TBL] [Abstract][Full Text] [Related]
17. Pharyngolaryngeal reflux in outpatient clinical practice: personal experience.
Galli J; Scarano S; Agostino S; Quaranta N; Cammarota G; Ottaviani F
Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):38-42. PubMed ID: 12812134
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux.
Amin MR; Postma GN; Johnson P; Digges N; Koufman JA
Otolaryngol Head Neck Surg; 2001 Oct; 125(4):374-8. PubMed ID: 11593175
[TBL] [Abstract][Full Text] [Related]
19. Potential relationship between gastroesophageal reflux disease and atrial arrhythmias.
Gerson LB; Friday K; Triadafilopoulos G
J Clin Gastroenterol; 2006 Oct; 40(9):828-32. PubMed ID: 17016140
[TBL] [Abstract][Full Text] [Related]
20. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
